Texas Eye & Laser Center is dedicated to offering quality services to our patients. Research is an essential aspect of our practice as it provides access to the technologies of tomorrow. We carefully choose the studies in which we participate because we are committed to our mission of creating vision to inspire the lives of our team, patients, and everyone we touch.
Texas Eye & Laser Center has been integral in helping gain approval for devices and technologies including:
- Corneal Crosslinking
- Intraoperative Aberrometry
- Intraocular Lens Implants
Thanks to our team’s involvement in the research of these and many more devices and technologies, countless patients have received the gift of new vision.
Our Research Team
Our research team is headed by Dr. Jerry Hu, with over 20 years’ experience in ophthalmic research. Our team also consists of two sub-investigators, Dr. M. Keith Head and Dr. D’Laine Heisterkamp. We currently have four full-time research staff members dedicated to clinical trials.
Texas Eye and Laser Center Clinical Research Department’s mission is to collect the highest quality data from well-informed, willing subjects to be used in the development of future technological advancements for the ophthalmologic field.
To be a top contributor to the field of ophthalmic advancements.
Safety- To do no harm to our patients or our staff. Protect the well-being of study participants.
Knowledge- Educate and empower our participants so that they can be fully informed and involved in our research.
Respect- It is our responsibility to treat all visitors to TELC with the same high level of esteem and provide them with elevated levels of eye care. We respect the choices of all patients- those who choose to participate in clinical trials and those who do not.
Integrity- Adhere to the highest standards of professionalism, ethics, and personal responsibility, worthy of the trust our patients place in us. Pursue service excellence through honesty and confidentiality.
Leadership- Be experts in our field and provide up-to-date technological advancements to our patients.
Compliance- Follow all rules, regulations, and laws while providing excellent patient care. Continual review of clinical study protocols to ensure strict adherence to guidelines.
Teamwork- Value the contributions of all research team members to blend the skills of individual staff members for a stronger research collaboration.
Accountability- Follow through on commitments. Take ownership of individual and team contributions to patient care.
Productivity- Do more with the efficient use of available resources.
Efficiency- Do things correctly the first time. Acknowledge errors and develop plans for improvement.
Current Enrolling Studies
TIOL-205-STPA; Post-Approval Study of TECNIS Symfony® Toric Lenses https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma_pas.cfm?t_id=587134&c_id=4064
NXGT-201-TTL2; Post-market Evaluation of Surgeon Feedback on TECNIS® Toric II IntraOcular Lens (IOL)
Allergan 1883-302-013; A Phase 3, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety and Efficacy of AGN-190584 in Participants with Presbyopia https://clinicaltrials.gov/ct2/show/NCT03804268
SUR-CAT-652-2001; Clinical Investigation of the Safety and Effectiveness of an Investigational Model of the TECNIS® Intraocular Lens
CTK246-P001; A prospective, multicenter, randomized evaluation of refractive predictability in patient with or without corneal astigmatism (maximum allowable up to 1.25 D) when using the Cataract Refractive Suite and standard manual techniques
ILH297-C001; Clinical Investigation of Acrysof® IQ PanOptix™ IOL Model TFNT00
SUR-CAT-652-1001; Clinical Investigation of the TECNIS® Next-Generation Intraocular Lenses
TELC-ORA-1001; Optimizing the Efficient use of Intraoperative Aberrometry in Cataract Surgery through an Analysis of the Necessity of Pseudophakic Confirmation in Toric Cases
TIOL-204-EPAS; Post-Approval Study of the TECNIS® Toric IOL Extended Cylinder Range (ECR), Models ZCT450, ZCT525 and ZCT600
DRYE-102-SELF; A Post-Market Evaluation of LipiFlow Treatment in Cataract Surgery Practice
Patients with mild to moderate Meibomian gland dysfunction (MGD) with cataracts who are scheduled to undergo cataract surgery with IOL implantation in both eyes
Interested in participating in a study?
If you have questions about any of our clinical research studies or are interested in joining one of the open studies, please feel free to contact us, wither by calling 817-540-6060 or using the web contact form. We will be happy to answer any questions you may have or arrange an appointment to evaluate your candidacy for any of our open research trials.